Director of Epigenetics and Cancer Prevention at Baylor Research Institute, Baylor University Medical Center, Dallas (TX, USA)
Ajay Goel is Director of Epigenetics and Cancer Prevention at Baylor Research Institute, Baylor University Medical Center in Dallas, TX. Dr Goel has spent 20 years researching cancer and has been the lead author or contributor to over 150 scientific articles published in peer reviewed international journals and several book chapters. He is also a primary inventor on more than 14 patents aimed at developing various biomarkers for the diagnosis, prognosis and prediction of gastrointestinal cancers. He is currently using advanced genomic and transcriptomic approaches to develop novel DNA- and microRNAbased biomarkers for the early detection of colorectal cancers. In addition, he is researching the prevention of gastrointestinal cancers using integrative and alternative approaches, including botanical products such as curcumin (from turmeric) and boswellia.
Dr Goel is a member of the American Association for Cancer Research (AACR) and the American Gastroenterology Association (AGA) and is on the international editorial boards of several journals including Gastroenterology, Clinical Cancer Research, PLoS ONE and World Journal of Gastroenterology. He is also actively involved in peer reviewing activities for more than 75 international scientific journals and various grant review panels of various national and international funding organizations. His research has been actively funded by various private and federal organizations, including funding from the National Institutes of Health (NIH) and American Cancer Society (ACS). His many awards include the Union of European Gastroenterology Federation’s Distinguished Researcher Award and multiple Posters of Distinction Awards from the AGA.